U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

Cross-feeding by Bifidobacterium breve UCC2003 during Bifidobacterium bifidum PRL2010 growth on a mucin-based medium.

(Submitter supplied) Bifidobacteria constitute commensal bacteria that commonly inhabit the mammalian gastro intestinal tract. The gut commensal Bifidobacterium breve UCC2003 was previously shown to utilise a variety of plant/diet-derived carbohydrates, including cellodextrin, starch and galactan. In the current study, we investigated the ability of this strain to utilize (parts of) a host-derived source of carbohydrate, namely the mucin glycoprotein. more...
Organism:
Bifidobacterium breve UCC2003
Type:
Expression profiling by array
Platform:
GPL8878
1 Sample
Download data: TXT
Series
Accession:
GSE59013
ID:
200059013
2.

Metabolism of sialic acid by Bifidobacterium breve UCC2003

(Submitter supplied) Bifidobacteria constitute a specific group of commensal bacteria which inhabit the gastrointestinal tract of humans and other mammals. Bifidobacterium breve UCC2003 has previously been shown to utilise several plant-derived carbohydrates that include cellodextrins, starch and galactan. In the current study, we investigate the ability of this strain to utilise the mucin- and human milk oligosaccharide (HMO)-derived carbohydrate, sialic acid. more...
Organism:
Bifidobacterium breve UCC2003
Type:
Expression profiling by array
Platform:
GPL8878
2 Samples
Download data: TXT
Series
Accession:
GSE56291
ID:
200056291
3.

Identification and characterization of a glycosulfatase-encoding gene cluster in Bifidobacterium breve UCC2003

(Submitter supplied) A bacterial nursling stool isolate, Bifidobacterium breve UCC2003, encodes two putative sulfatases. The sulfated monosaccharide N-acetylglucosamine-6-sulfate (GlcNAc-6-S) was shown to support growth of B. breve UCC2003, while three other tested sulfated monosaccharides, N-acetylglucosamine-3-sulfate, N-acetylgalactosamine-3-sulfate and N-acetylgalactosamine-6-sulfate, did not. Using a combination of transcriptomic and functional genomic approaches, a gene cluster, designated ats2, was shown to be specifically required for GlcNAc-6-S metabolism. more...
Organism:
Bifidobacterium breve UCC2003
Type:
Expression profiling by array
Platform:
GPL8878
4 Samples
Download data: TXT
Series
Accession:
GSE81240
ID:
200081240
4.

Carbohydrate Syntrophy enhances the establishment of Bifidobacterium breve UCC2003 in the neonatal gut

(Submitter supplied) To extend our understanding of bifidobacterial mutualism and carbohydrate syntrophy in the gut we adopted advanced functional genomics to create single- and double-deletion isogenic strains of the NagA encoding genes of B. breve UCC2003. The resulting strains were examined, as compared to the parent strain, for their ability to metabolise particular host derived carbohydrates. In addition, the B. breve strains were examined for their crossfeeding capability and ability to establish, in the presence of B. more...
Organism:
Bifidobacterium breve UCC2003
Type:
Expression profiling by array
Platform:
GPL8878
2 Samples
Download data: TXT
Series
Accession:
GSE110077
ID:
200110077
5.

Bifidobacterium breve UCC2003 employs multiple transcriptional regulators in a series of glycan-induced positive feedback loops to regulate HMO metabolism

(Submitter supplied) Regulation of carbohydrate metabolism in Bifidobacterium breve has been studied in detail for a variety of both plant and human-derived glycans, particularly in the model strain UCC2003. We have recently comprehensively elucidated the precise metabolic pathways by which the human milk oligosaccharide (HMO) components LNT, LNnT and LNB are utilized by B. breve UCC2003. However, no work has been carried out to date in identifying and understanding the regulatory mechanisms that control transcription of the genetic loci involved in these metabolic pathways. more...
Organism:
Bifidobacterium breve UCC2003
Type:
Expression profiling by array
Platforms:
GPL24137 GPL24138
8 Samples
Download data: TXT
Series
Accession:
GSE105108
ID:
200105108
6.

Effects of Bifidobacterium bifidum PRL2010 on gene expression in intestinal epithelial cells

(Submitter supplied) Analysis of gene expression in Caco-2 intestinal epithelial cells stimulated with Bifidobacterium bifidum PRL2010. We used microarrays to investigate gene expression in intestinal epithelial cells in response to Bifidobacterium bifidum PRL2010, in particular genes involved in mucin pathways.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL7020
8 Samples
Download data: CEL
Series
Accession:
GSE21976
ID:
200021976
7.

Molecular response of bifidobacteria to a cholesterol rich environment

(Submitter supplied) We investigated the capabilities of bifidobacteria to reduce the cholesterol level in the media, which clearly evidenced a high ratio of assimilation of this molecule by specific bifidobacterial strains including Bifidobacterium bifidum PRL2010. The transcriptomics of PRL2010 cells cultivated in the presence of cholesterol evidenced a significant higher expression of carriers as well as reductase encoding genes
Organism:
Bifidobacterium bifidum PRL2010
Type:
Expression profiling by array
Platform:
GPL13951
6 Samples
Download data: TXT
Series
Accession:
GSE63661
ID:
200063661
8.

The cross talk occurring between bifidobacteria in the mammalian's gut microbiota

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088; Bifidobacterium adolescentis; Bifidobacterium breve 12L; Bifidobacterium bifidum PRL2010
Type:
Expression profiling by array
Platform:
GPL19766
20 Samples
Download data: TXT
Series
Accession:
GSE65829
ID:
200065829
9.

The cross talk occurring between bifidobacteria in the mammalian’s gut microbiota [PRL]

(Submitter supplied) We describe the molecular cross talk established under in vivo conditions between a set of human gut bifidobacterial commensals. Eleven groups of five conventional female 8-wk-old BALB/c mice taking a standard polysaccharide-rich Chow diet were administered a single daily dose of 109 CFU of either B. bifidum PRL2010, B. breve 12L , B. adolescentis 22L , B. longum subsp. infantis ATCC15697, or bifidobacterial couples, i.e., PRL2010-12L, PRL2010-22L, PRL2010-ATCC15696, 12L-22L, 12L-ATCC15697, 22L-ATCC15697, or a combination of all bifidobacterial strains. more...
Organism:
Bifidobacterium breve 12L; Bifidobacterium adolescentis; Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088; Bifidobacterium bifidum PRL2010
Type:
Expression profiling by array
Platform:
GPL19766
5 Samples
Download data: TXT
Series
Accession:
GSE65828
ID:
200065828
10.

The cross talk occurring between bifidobacteria in the mammalian’s gut microbiota [ATCC15697]

(Submitter supplied) We describe the molecular cross talk established under in vivo conditions between a set of human gut bifidobacterial commensals. Eleven groups of five conventional female 8-wk-old BALB/c mice taking a standard polysaccharide-rich Chow diet were administered a single daily dose of 109 CFU of either B. bifidum PRL2010, B. breve 12L , B. adolescentis 22L , B. longum subsp. infantis ATCC15697, or bifidobacterial couples, i.e., PRL2010-12L, PRL2010-22L, PRL2010-ATCC15696, 12L-22L, 12L-ATCC15697, 22L-ATCC15697, or a combination of all bifidobacterial strains. more...
Organism:
Bifidobacterium adolescentis; Bifidobacterium breve 12L; Bifidobacterium bifidum PRL2010; Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088
Type:
Expression profiling by array
Platform:
GPL19766
5 Samples
Download data: TXT
Series
Accession:
GSE65826
ID:
200065826
11.

The cross talk occurring between bifidobacteria in the mammalian’s gut microbiota [22L]

(Submitter supplied) We describe the molecular cross talk established under in vivo conditions between a set of human gut bifidobacterial commensals. Eleven groups of five conventional female 8-wk-old BALB/c mice taking a standard polysaccharide-rich Chow diet were administered a single daily dose of 109 CFU of either B. bifidum PRL2010, B. breve 12L , B. adolescentis 22L , B. longum subsp. infantis ATCC15697, or bifidobacterial couples, i.e., PRL2010-12L, PRL2010-22L, PRL2010-ATCC15696, 12L-22L, 12L-ATCC15697, 22L-ATCC15697, or a combination of all bifidobacterial strains. more...
Organism:
Bifidobacterium bifidum PRL2010; Bifidobacterium breve 12L; Bifidobacterium adolescentis; Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088
Type:
Expression profiling by array
Platform:
GPL19766
5 Samples
Download data: TXT
Series
Accession:
GSE65825
ID:
200065825
12.

The cross talk occurring between bifidobacteria in the mammalian’s gut microbiota [12L]

(Submitter supplied) We describe the molecular cross talk established under in vivo conditions between a set of human gut bifidobacterial commensals. Eleven groups of five conventional female 8-wk-old BALB/c mice taking a standard polysaccharide-rich Chow diet were administered a single daily dose of 109 CFU of either B. bifidum PRL2010, B. breve 12L , B. adolescentis 22L , B. longum subsp. infantis ATCC15697, or bifidobacterial couples, i.e., PRL2010-12L, PRL2010-22L, PRL2010-ATCC15696, 12L-22L, 12L-ATCC15697, 22L-ATCC15697, or a combination of all bifidobacterial strains. more...
Organism:
Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088; Bifidobacterium bifidum PRL2010; Bifidobacterium breve 12L; Bifidobacterium adolescentis
Type:
Expression profiling by array
Platform:
GPL19766
5 Samples
Download data: TXT
Series
Accession:
GSE65822
ID:
200065822
13.

Metabolism of four α-glycosidic linkage-containing oligosaccharides by Bifidobacterium breve UCC2003

(Submitter supplied) Members of the genus Bifidobacterium are common inhabitants of the gastrointestinal tract of humans and other mammals, where they ferment many diet-derived carbohydrates that cannot be digested by their host. To extend our understanding of bifidobacterial carbohydrate utilisation, we investigated the molecular mechanisms by which various strains of Bifidobacterium breve metabolize four distinct α-glucose and/or α-galactose-containing oligosaccharides, namely raffinose, stachyose, melibiose and melezitose. more...
Organism:
Bifidobacterium breve UCC2003; Bifidobacterium breve
Type:
Expression profiling by array
Platform:
GPL8878
6 Samples
Download data: TXT
Series
Accession:
GSE47448
ID:
200047448
14.

Transcriptional regulation of the sialic acid utilization gene cluster of Bifidobacterium breve UCC2003 by a GntR-type transcriptional repressor.

(Submitter supplied) Members of the genus Bifidobacterium are typically found in the gastrointestinal tract (GIT) of humans and other mammals. Bifidobacterium breve strains are numerically prevalent among the gut microbiota of healthy, breast-fed infants. The metabolism of sialic acid, a ubiquitous monosaccharide in the infant and adult gut, by B. breve UCC2003 is dependent on a large gene cluster, designated the nan/nag cluster. more...
Organism:
Bifidobacterium breve UCC2003
Type:
Expression profiling by array
Platform:
GPL8878
2 Samples
Download data: TXT
Series
Accession:
GSE62885
ID:
200062885
15.

RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides.

(Submitter supplied) Background: Breastfed human infants are predominantly colonized by bifidobacteria that thrive on human milk oligosaccharides (HMO). The two most predominant species of bifidobacteria in infant feces are Bifidobacterium breve (B. breve) and Bifidobacterium longum subsp. infantis (B. infantis), both avid HMO-consumer strains. Our laboratory has previously shown that B. infantis, when grown on HMO, increase adhesion to intestinal cells and increase the expression of the anti-inflammatory cytokine interleukin-10. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL11154
9 Samples
Download data: XLSX
16.

RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides.

(Submitter supplied) Background: Breastfed human infants are predominantly colonized by bifidobacteria that thrive on human milk oligosaccharides (HMO). The two most predominant species of bifidobacteria in infant feces are Bifidobacterium breve (B. breve) and Bifidobacterium longum subsp. infantis (B. infantis), both avid HMO-consumer strains. Our laboratory has previously shown that B. infantis, when grown on HMO, increase adhesion to intestinal cells and increase the expression of the anti-inflammatory cytokine interleukin-10. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL11154
9 Samples
Download data: XLSX
17.

RNA sequencing of Bifidobacterium bifidum SC555 in response to various substrates

(Submitter supplied) The purpose of this project was to determine the whole transcriptome response of Bifidobacterium bifidum SC555 to pooled and individual human milk oligosaccharides (HMO) relative to lactose
Organism:
Bifidobacterium bifidum
Type:
Expression profiling by high throughput sequencing
Platform:
GPL18891
20 Samples
Download data: TXT
Series
Accession:
GSE59053
ID:
200059053
18.

RNA sequencing of Bifidobacterium longum subsp. infantis in response to various substrates

(Submitter supplied) The purpose of this project was to determine the whole transcriptome response of Bifidobacterium longum subsp. Infantis to pooled and individual human milk oligosaccharides (HMO) relative to lactose
Organism:
Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088
Type:
Expression profiling by high throughput sequencing
Platform:
GPL18859
18 Samples
Download data: TXT
Series
Accession:
GSE58773
ID:
200058773
19.

Bifidobacterium breve UCC2003 metabolizes lacto-N-tetraose and lacto-N-neo-tetraose through overlapping, yet distinct pathways

(Submitter supplied) Recent studies have begun to elucidate the mechanisms of utilisation of some human milk oligosaccharides (HMO) components by Bifidobacterium breve. However, this phenomenon is still relatively poorly understood, with little to no work to date in understanding a number of specific structures common to HMO.   In this study, we demonstrate that the prototype B. breve strain UCC2003 possesses specific metabolic pathways for the utilisation of Lacto-N-Tetraose and Lacto-N-neoTetraose, which represent the central moieties of Type I and Type II HMOs, respectively. more...
Organism:
Bifidobacterium breve UCC2003
Type:
Expression profiling by array
Platform:
GPL13210
10 Samples
Download data: TXT
Series
Accession:
GSE84710
ID:
200084710
20.

Functional genome analysis of Bifidobacterium breve UCC2003 reveals a major conserved host-colonization factor

(Submitter supplied) Development of the human gut microbiota commences at birth with bifidobacteria being among the first colonizers of the sterile newborn gastrointestinal tract. To date the genetic basis of bifidobacterial colonization and persistence remains poorly understood. Transcriptomic analysis of the 2,422,684 bp genome of Bifidobacterium breve UCC2003, a strain isolated from a nursling stool, during colonization of a mouse model revealed the differential expression of a type IVb or so-called Tad pilus-encoding cluster. more...
Organism:
Mus musculus; Bifidobacterium breve UCC2003; Bifidobacterium breve
Type:
Expression profiling by array; Genome variation profiling by array
Platforms:
GPL13210 GPL8878
21 Samples
Download data: TXT
Series
Accession:
GSE27491
ID:
200027491
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=10|blobid=MCID_677b41f37eb86f557f960c8b|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center